Surgery pp 943-961 | Cite as


  • Courtney Scaife


The liver develops from a branching diverticular outpouching of the foregut in the fifth to seventh weeks of development. This gives rise to the hepatic cords, the secretory tubules of the liver, and the primary hepatic ducts. Fully developed, the liver is the largest parenchymal organ in the body and accounts for approximately 4% to 5% of the total body weight.


Portal Hypertension Hepatic Resection Transjugular Intrahepatic Portosystemic Shunt National Comprehensive Cancer Network Colorectal Liver Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Couinaud C. [Surgical anatomy of the liver. Several new aspects]. Chirurgie 1986;112:337–342.PubMedGoogle Scholar
  2. 2.
    Prandi D, Dumont M, et al. Influence of portacaval shunt on bile formation in the rat. Eur J Clin Invest 1975;4:197–200.CrossRefGoogle Scholar
  3. 3.
    Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am 1975;59:995–1013.PubMedGoogle Scholar
  4. 4.
    Mergo PJ, Ros PR. Benign lesions of the liver. Radiol Clin North Am 1998;36:319–331.PubMedCrossRefGoogle Scholar
  5. 5.
    Trotter JF, Everson GT. Benign focal lesions of the liver. Clin Liver Dis 2001;5:17–42, v.PubMedCrossRefGoogle Scholar
  6. 6.
    Nichols FC 3rd, van Heerden JA, et al. Benign liver tumors. Surg Clin North Am 1989;69:297–314.PubMedGoogle Scholar
  7. 7.
    Horton KM, Bluemke DA, et al. CT and MR imaging of benign hepatic and biliary tumors. Radiographics 1999;19:431–451.PubMedGoogle Scholar
  8. 8.
    Yoon SS, Charny CK, et al. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma. J Am Coll Surg 2003;197:392–402.PubMedCrossRefGoogle Scholar
  9. 9.
    Wanless IR, Mawdsley C, et al. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985;5:1194–1200.PubMedCrossRefGoogle Scholar
  10. 10.
    Scalori A, Tavani A, et al. Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. Am J Obstet Gynecol 2002;186:195–197.PubMedCrossRefGoogle Scholar
  11. 11.
    Vauthey JN. Liver imaging. A surgeon’s perspective. Radiol Clin North Am 1998;36:445–457.PubMedCrossRefGoogle Scholar
  12. 12.
    Janes CH, McGill DB, et al. Liver cell adenoma at the age of 3 years and transplantation 19 years later after development of carcinoma: a case report. Hepatology 1993;17:583–585.PubMedCrossRefGoogle Scholar
  13. 13.
    Grazioli L, Federle MP, et al. Hepatic adenomas: imaging and pathologic findings. Radiographics 2001;21:877–892; discussion 892–894.PubMedGoogle Scholar
  14. 14.
    Biecker E, Fischer HP, et al. Benign hepatic tumours. Z Gastroenterol 2003;41:191–200.PubMedCrossRefGoogle Scholar
  15. 15.
    Mortele KJ, Ros PR. Benign liver neoplasms. Clin Liver Dis 2002;6:119–145.PubMedCrossRefGoogle Scholar
  16. 16.
    Tesluk H, Lawrie J. Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives. Arch Pathol Lab Med 1981;105:296–299.PubMedGoogle Scholar
  17. 17.
    Coutsoftides T, Hermann RE. Nonparasitic cysts of the liver. Surg Gynecol Obstet 1974;138:906–910.PubMedGoogle Scholar
  18. 18.
    Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol 2003;58:626–629.PubMedCrossRefGoogle Scholar
  19. 19.
    Longmire WP Jr, WP, SA, Jr, Mandiola SA, et al. Congenital cystic disease of the liver and biliary system. Ann Surg 1971;174:711–726.PubMedCrossRefGoogle Scholar
  20. 20.
    Dardik H, Glotzer P, et al. Congenital hepatic cyst causing jaundice: report of a case and analogies with respiratory malformations. Ann Surg 1964;159:585–592.PubMedCrossRefGoogle Scholar
  21. 21.
    Campbell GS, Bick HD, et al. Bleeding esophageal varices with polycystic liver; report of three cases. N Engl J Med 1958;259:904–910.PubMedGoogle Scholar
  22. 22.
    Landing BH, Wells TR, et al. Morphometric analysis of liver lesions in cystic diseases of childhood. Hum Pathol 1980;11(5 suppl):549–560.PubMedGoogle Scholar
  23. 23.
    Everson GT, Taylor MR. Management of polycystic liver disease. Curr Gastrointerol Rep 2005;7:19–25.CrossRefGoogle Scholar
  24. 24.
    Li A, Davila S, et al. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 2003;72:691–703.PubMedCrossRefGoogle Scholar
  25. 25.
    Gabow PA, Johnson AM, et al. Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 1990;11:1033–1037.PubMedCrossRefGoogle Scholar
  26. 26.
    Melnick PJ. Polycystic liver; analysis of 70 cases. AMA Arch Pathol 1955;59:162–172.PubMedGoogle Scholar
  27. 27.
    Everson GT, Taylor MR, et al. Polycystic disease of the liver. Hepatology 2004;40:774–782.PubMedGoogle Scholar
  28. 28.
    Montorsi M, Torzilli G, et al. Percutaneous alcohol sclerotherapy of simple hepatic cysts. Results from a multicentre survey in Italy. HPB Surg 1994;8:89–94.PubMedCrossRefGoogle Scholar
  29. 29.
    Larssen TB, Jensen DK, et al. Single-session alcohol sclerotherapy in symptomatic benign hepatic cysts. Long-term results. Acta Radiol 1999;40:636–638.PubMedGoogle Scholar
  30. 30.
    Tocchi A, Mazzoni G, et al. Symptomatic nonparasitic hepatic cysts: options for and results of surgical management. Arch Surg 2002;137:154–158.PubMedCrossRefGoogle Scholar
  31. 31.
    Yang GS, Li QG, et al. Combined hepatic resection with fenestration for highly symptomatic polycystic liver disease: a report on seven patients. World J Gastroenterol 2004;10:2598–2601.PubMedGoogle Scholar
  32. 32.
    Katkhouda N, Mavor E, et al. Laparoscopic management of benign cystic lesions of the liver. J Hepatobiliary Pancreat Surg 2000;7:212–217.PubMedCrossRefGoogle Scholar
  33. 33.
    Gigot JF, Glineur D, et al. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 2002;236:90–97.PubMedCrossRefGoogle Scholar
  34. 34.
    Chen BK, Gamagami RA, et al. Symptomatic post-traumatic cyst of the liver: treatment by laparoscopic surgery. J Laparoendosc Adv Surg Tech A 2001;11:41–42.PubMedCrossRefGoogle Scholar
  35. 35.
    Kaushik S, Fulcher AS, et al. Segmental hepatic atrophy: a sequela of blunt intrahepatic bile duct injury. J Trauma 2003;54:1225–1227.PubMedCrossRefGoogle Scholar
  36. 36.
    Dixon E, Sutherland FR, et al. Cystadenomas of the liver: a spectrum of disease. Can J Surg 2001;44:371–376.PubMedGoogle Scholar
  37. 37.
    Korobkin M, Stephens DH, et al. Biliary cystadenoma and cyst-adenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol 1989;153:507–511.PubMedGoogle Scholar
  38. 38.
    Devine P, Ucci AA. Biliary cystadenocarcinoma arising in a congenital cyst. Hum Pathol 1985;16:92–94.PubMedCrossRefGoogle Scholar
  39. 39.
    Hansman MF, Ryan JA Jr, et al. Management and long-term follow-up of hepatic cysts. Am J Surg 2001;181:404–410.PubMedCrossRefGoogle Scholar
  40. 40.
    Sanchez H, Gagner M, et al. Surgical management of nonparasitic cystic liver disease. Am J Surg 1991;161:113–118; discussion 118–119.PubMedCrossRefGoogle Scholar
  41. 41.
    Lauffer JM, Baer HU, et al. Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer 1998;34:1845–1851.PubMedCrossRefGoogle Scholar
  42. 42.
    Moro FL, Gonzalez AE, Gilman RH. Larval cestode infections. In: Cystic hydatid, disease. Hunter’s Tropical Medicine. Philadelphia: Saunders; 1984;866.Google Scholar
  43. 43.
    Zaouche A, Haouet K, et al. Management of liver hydatid cysts with a large biliocystic fistula: multicenter retrospective study. Tunisian Surgical Association. World J Surg 2001;25:28–39.PubMedCrossRefGoogle Scholar
  44. 44.
    Garti I, Deutsch V. The angiographic diagnosis of echinococcosis of the liver and spleen. Clin Radiol 1971;22:466–471.PubMedCrossRefGoogle Scholar
  45. 45.
    Lewall DB. Hydatid disease: biology, pathology, imaging and classification. Clin Radiol 1998;53:863–874.PubMedCrossRefGoogle Scholar
  46. 46.
    Lorenzo C, Ferreira HB, et al. Comparative analysis of the diagnostic performance of six major Echinococcus granulosus antigens assessed in a double-blind, randomized multicenter study. J Clin Microbiol 2005;43:2764–2770.PubMedCrossRefGoogle Scholar
  47. 47.
    von Sinner WN, Nyman R, et al. Fine needle aspiration biopsy of hydatid cysts. Acta Radiol 1995;36:168–172.Google Scholar
  48. 48.
    Olcay L, Besim LA, et al. Hydatid cyst mimicking pulmonary hematoma in a patient with hemophilia A. Turk J Pediatr 1998;40:425–429.PubMedGoogle Scholar
  49. 49.
    Gil-Grande LA, Rodriguez-Caabeiro F, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet 1993;342:1269–1272.PubMedCrossRefGoogle Scholar
  50. 50.
    Franchi C, Di Vico B, et al. Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamates. Clin Infect Dis 1999;29:304–309.PubMedCrossRefGoogle Scholar
  51. 51.
    Keshmiri M, Baharvahdat H, et al. Albendazole versus placebo in treatment of echinococcosis. Trans R Soc Trop Med Hyg 2001;95:190–194.PubMedCrossRefGoogle Scholar
  52. 52.
    Morris DL, Dykes PW, et al. Albendazole-objective evidence of response in human hydatid disease. JAMA 1985;253:2053–2057.PubMedCrossRefGoogle Scholar
  53. 53.
    Nahmias J, Goldsmith R, et al. Three-to 7-year follow-up after albendazole treatment of 68 patients with cystic echinococcosis (hydatid disease). Ann Trop Med Parasitol 1994;88:295–304.PubMedGoogle Scholar
  54. 54.
    Khuroo MS, Wani NA, et al. Percutaneous drainage compared with surgery for hepatic hydatid cysts. N Engl J Med 1997;337:881–887.PubMedCrossRefGoogle Scholar
  55. 55.
    Smego RA Jr, Bhatti S, et al. Percutaneous aspiration-injection-reaspiration drainage plus albendazole or mebendazole for hepatic cystic echinococcosis: a meta-analysis. Clin Infect Dis 2003;37:1073–1083.PubMedCrossRefGoogle Scholar
  56. 56.
    Emel’ianov SI, Khamidov MA. [Laparoscopic treatment of hydatid liver cysts]. Khirurgiia (Mosk) 2000;(11):32–34.Google Scholar
  57. 57.
    Dziri C, Haouet K, et al. Treatment of hydatid cyst of the liver: where is the evidence? World J Surg 2004;28:731–736.PubMedCrossRefGoogle Scholar
  58. 58.
    Bosch FX, Ribes J, et al. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2005;9:191–211, v.PubMedCrossRefGoogle Scholar
  59. 59.
    Merle P. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma.]. Cancer Radiother 2005;9:452–457.PubMedGoogle Scholar
  60. 60.
    femal A, Murray T, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10–30.CrossRefGoogle Scholar
  61. 61.
    Jemal A, Ward E, et al. Trends in the leading causes of death in the United States, 1970–2002. JAMA 2005;294:1255–1259.PubMedCrossRefGoogle Scholar
  62. 62.
    Okuda K, Ohtsuki T, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918–928.PubMedCrossRefGoogle Scholar
  63. 63.
    Okuda K. Hepatocellular carcinoma: recent progress. Hepatology 1992;15:948–963.PubMedCrossRefGoogle Scholar
  64. 64.
    Tsukuma H, Hiyama T, et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993;328:1797–1801.PubMedCrossRefGoogle Scholar
  65. 65.
    Kew MC. Tumour markers of hepatocellular carcinoma. J Gastroenterol Hepatol 1989;4:373–384.PubMedCrossRefGoogle Scholar
  66. 66.
    McMahon BJ, London T. Workshop on screening for hepatocellular carcinoma. J Natl Cancer Inst 1991;83:916–919.PubMedCrossRefGoogle Scholar
  67. 67.
    Wee A. Fine needle aspiration biopsy of the liver: algorithmic approach and current issues in the diagnosis of hepatocellular carcinoma. Cytojournal 2005;2:7.PubMedCrossRefGoogle Scholar
  68. 68.
    Zoli M, Magalotti D, et al. Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer 1996;78:977–985.PubMedCrossRefGoogle Scholar
  69. 69.
    El-Serag HB, Anand B, et al. Association between hepatitis C infection and other infectious diseases: a case for targeted screening? Am J Gastroenterol 2003;98:167–174.PubMedCrossRefGoogle Scholar
  70. 70.
    Cusnir M, Patt YZ. Novel systemic therapy options for hepatocellular carcinoma. Cancer J 2004;10:97–103.PubMedCrossRefGoogle Scholar
  71. 71.
    Sherman M. Screening for hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005;19:101–118.PubMedCrossRefGoogle Scholar
  72. 72.
    Curley SA, Izzo F, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381–391.PubMedCrossRefGoogle Scholar
  73. 73.
    Sherman M, Peltekian KM, et al. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995;22:432–438.PubMedGoogle Scholar
  74. 74.
    Wildi S, Pestalozzi BC, et al. Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 2004;91:400–408.PubMedCrossRefGoogle Scholar
  75. 75.
    Marrero JA, Fontana RJ, et al. Prognosis of hepatocellular carcinoma: comparison of seven staging systems in an American cohort. Hepatology 2005;41:707–716.PubMedCrossRefGoogle Scholar
  76. 76.
    Zhao WH, Ma ZM, et al. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002;8:237–242.PubMedGoogle Scholar
  77. 77.
    Shabahang M, Franceschi D, et al. Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol 2002;9:881–886.PubMedCrossRefGoogle Scholar
  78. 78.
    Cha CH, Ruo L, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003;238:315–321; discussion 321–323.PubMedGoogle Scholar
  79. 79.
    Yoo HY, Patt CH, et al. The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time. J Clin Oncol 2003;21:4329–4335.PubMedCrossRefGoogle Scholar
  80. 80.
    Poon RT, Fan ST. Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 2004;10(2 suppl 1):S39–S45.PubMedCrossRefGoogle Scholar
  81. 81.
    Schoniger-Hekele M, Muller C, et al. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut 2001;48:103–109.PubMedCrossRefGoogle Scholar
  82. 82.
    Fong Y, Blumgart LH. Hepatic colorectal metastasis: current status of surgical therapy. Oncology (Williston Park) 1998;12:1489–1498; discussion 1498–1500, 1503.Google Scholar
  83. 83.
    Poon RT, Fan ST, et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999;229:216–222.PubMedCrossRefGoogle Scholar
  84. 84.
    Nagasue N, Yukaya H, et al. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986;99:694–701.PubMedGoogle Scholar
  85. 85.
    Kamath PS, Wiesner RH, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–470.PubMedCrossRefGoogle Scholar
  86. 86.
    Huang YH, Wu JC, et al. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients. Eur J Gastroenterol Hepatol 1999;11:315–321.PubMedGoogle Scholar
  87. 87.
    Schneider PD. Preoperative assessment of liver function. Surg Clin North Am 2004;84:355–373.PubMedCrossRefGoogle Scholar
  88. 88.
    Lao XM, Zhang YQ, et al. [Estimation of hepatic resection volume in hepatocellular carcinoma by ICG(R15) and its relation with postoperative liver failure]. Ai Zheng 2005;24:337–340.PubMedGoogle Scholar
  89. 89.
    Oldhafer KJ, Hogemann D, et al. [3-dimensional (3-D) visualization of the liver for planning extensive liver resections]. Chirurg 1999;70:233–238.PubMedCrossRefGoogle Scholar
  90. 90.
    Lang H, Radtke A, et al. Extended left hepatectomy–modified operation planning based on three-dimensional visualization of liver anatomy. Langenbecks Arch Surg 2004;389:306–310.PubMedCrossRefGoogle Scholar
  91. 91.
    Madoff DC, Abdalla EK, et al. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care. J Vasc Interv Radiol 2005;16:779–790.PubMedGoogle Scholar
  92. 92.
    Hemming AW, Reed AI, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003;237:686–691; discussion 691–693.PubMedCrossRefGoogle Scholar
  93. 93.
    Lai EC, Ng IO, et al. Hepatic resection for small hepatocellular carcinoma: the Queen Mary Hospital experience. World J Surg 1991;15:654–659.PubMedCrossRefGoogle Scholar
  94. 94.
    Poon RT, Fan ST, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001;234:63–70.PubMedCrossRefGoogle Scholar
  95. 95.
    Nagasue N, Ono T, et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 2001;88:515–522.PubMedCrossRefGoogle Scholar
  96. 96.
    Yeh CN, Chen MF, et al. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol 2002;81:195–202.PubMedCrossRefGoogle Scholar
  97. 97.
    Mazzaferro V, Regalia E, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.PubMedCrossRefGoogle Scholar
  98. 98.
    Poon RT, Ngan H, et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol 2000;73:109–114.PubMedCrossRefGoogle Scholar
  99. 99.
    Lo CM, Ngan H, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 2002;35:1164–1171.PubMedCrossRefGoogle Scholar
  100. 100.
    Camma C, Schepis F, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002;224:47–54.PubMedCrossRefGoogle Scholar
  101. 101.
    Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429–442.PubMedCrossRefGoogle Scholar
  102. 102.
    Livraghi T, Giorgio A, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101–108.PubMedGoogle Scholar
  103. 103.
    Livraghi T, Goldberg SN, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000;214:761–768.PubMedGoogle Scholar
  104. 104.
    Yamamoto J, Okada S, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology 2001;34(4 pt 1):707–713.PubMedCrossRefGoogle Scholar
  105. 105.
    Jatzko G, Wette V, et al. Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital. Int J Colorectal Dis 1991;6:111–114.PubMedCrossRefGoogle Scholar
  106. 106.
    Scheele J, Stangl R, et al. Staging of resectable colorectal liver metastases. Surgery 1996;119:118–120.PubMedCrossRefGoogle Scholar
  107. 107.
    Scheele J, Altendorf-Hofmann A, et al. [Resection of colorectal liver metastases. What prognostic factors determine patient selection?]. Chirurg 2001;72:547–560.PubMedCrossRefGoogle Scholar
  108. 108.
    Fernandez FG, Drebin JA, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 2004;240:438–447; discussion 447–450.PubMedCrossRefGoogle Scholar
  109. 109.
    Folprecht G, Grothey A, et al. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005;16:1311–1319.PubMedCrossRefGoogle Scholar
  110. 110.
    DeMatteo RP, Palese C, et al. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 2000;4:178–184.PubMedCrossRefGoogle Scholar
  111. 111.
    Weber SM, Jarnagin WR, et al. Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes. J Am Coll Surg 2001;193:384–391.PubMedCrossRefGoogle Scholar
  112. 112.
    Jarnagin WR, Gonen M, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg 2002;236:397–406; discussion 406–407.PubMedCrossRefGoogle Scholar
  113. 113.
    Ekberg H, Tranberg KG, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg 1986;73:727–731.PubMedCrossRefGoogle Scholar
  114. 114.
    Hughes KS, Simon R, et al. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986;100:278–284.PubMedGoogle Scholar
  115. 115.
    Weber SM, Jarnagin WR, et al. Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 2000;7:643–650.PubMedCrossRefGoogle Scholar
  116. 116.
    Poston G, Adam, R, et al. OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clinic Oncol 2005;23:7125–7134.CrossRefGoogle Scholar
  117. 117.
    Wray CJ, Lowy AM, et al. The significance and clinical factors associated with a subcentimeter resection of colorectal liver metastases. Ann Surg Oncol 2005;12:374–380.PubMedCrossRefGoogle Scholar
  118. 118.
    Curley SA, Marra P, et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004;239:450–458.PubMedCrossRefGoogle Scholar
  119. 119.
    Goldberg RM, Sargent DJ, et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23–30.PubMedCrossRefGoogle Scholar
  120. 120.
    Tournigand C, Andre T, et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004;22:229–237.PubMedCrossRefGoogle Scholar
  121. 121.
    Adam R, Avisar E, et al. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 2001;8:347–353.PubMedCrossRefGoogle Scholar
  122. 122.
    Delaunoit T, Alberts SR, et al. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 2005;16:425–429.PubMedCrossRefGoogle Scholar
  123. 123.
    Schefter TE, Kavanagh BD, et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005;62:1371–1378.PubMedGoogle Scholar
  124. 124.
    Weitz J, Blumgart LH, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 2005;241:269–276.PubMedCrossRefGoogle Scholar
  125. 125.
    Chamberlain RS, Canes D, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000;190:432–445.PubMedCrossRefGoogle Scholar
  126. 126.
    Sarmiento JM, Que FG. Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 2003;12:231–242.PubMedCrossRefGoogle Scholar
  127. 127.
    Gupta S, Johnson MM, et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors. Cancer 2005;104:1590–1602.PubMedCrossRefGoogle Scholar
  128. 128.
    Nakeeb A, Pitt HA, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463–473; discussion 473–475.PubMedCrossRefGoogle Scholar
  129. 129.
    Takayasu K, Choi B, et al. First International Symposium of Current Issues for Nationwide Survey of Primary Liver Cancer in Korea, Taiwan and Japan. Japanese J Clinic Oncol 2007;37(3):233–240.CrossRefGoogle Scholar
  130. 130.
    Sons HU, Borchard F. Carcinoma of the extrahepatic bile ducts: a postmortem study of 65 cases and review of the literature. J Surg Oncol 1987;34:6–12.PubMedCrossRefGoogle Scholar
  131. 131.
    Pitt HA, Dooley WC, et al. Malignancies of the biliary tree. Curr Probl Surg 1995;32:1–90.PubMedCrossRefGoogle Scholar
  132. 132.
    Yamashita Y, Takahashi M, et al. Parenchymal changes of the liver in cholangiocarcinoma: CT evaluation. Gastrointest Radiol 1992;17:161–166.PubMedCrossRefGoogle Scholar
  133. 133.
    Wiersema MJ, Vilmann P, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997;112:1087–1095.PubMedCrossRefGoogle Scholar
  134. 134.
    Teefey SA, Hildeboldt CC, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology 2003;226:533–542.PubMedCrossRefGoogle Scholar
  135. 135.
    Nimura Y. Extended surgery in bilio-pancreatic cancer: the Japanese experience. Semin Oncol 2002;29(6 suppl 20):17–22.PubMedGoogle Scholar
  136. 136.
    Hanazaki K, Kajikawa S, et al. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 2002;49:311–316.PubMedGoogle Scholar
  137. 137.
    Lang H, Sotiropoulos GC, et al. Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC):when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 2005;241:134–143.PubMedGoogle Scholar
  138. 138.
    Boyer TD. Natural history of portal hypertension. Clin Liver Dis 1997;1:31–44, x.PubMedCrossRefGoogle Scholar
  139. 139.
    Le Moine O, Hadengue A, et al. Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis. Scand J Gastroenterol 1997;32:731–735.PubMedCrossRefGoogle Scholar
  140. 140.
    de Franchis R, Dell’Era A, et al. Diagnosis and treatment of portal hypertension. Dig Liver Dis 2004;36:787–798.PubMedCrossRefGoogle Scholar
  141. 141.
    Benvegnu L, Gios M, et al. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications. Gut 2004;53:744–749.PubMedCrossRefGoogle Scholar
  142. 142.
    Planas R, Balleste B, et al. Natural history of decompensated hepatitis C virus-related cirrhosis. A study of 200 patients. J Hepatol 2004;40:823–830.PubMedCrossRefGoogle Scholar
  143. 143.
    Burroughs AK. The natural history of varices. J Hepatol 1993;17(suppl 2):S10–S13.PubMedCrossRefGoogle Scholar
  144. 144.
    Sarin SK, Lamba GS, et al. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999;340:988–993.PubMedCrossRefGoogle Scholar
  145. 145.
    Jutabha R, Jensen DM, et al. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology 2005;128:870–881.PubMedCrossRefGoogle Scholar
  146. 146.
    Psilopoulos D, Galanis P, et al. Endoscopic variceal ligation versus propranolol for prevention of first variceal bleeding: a randomized controlled trial. Eur J Gastroenterol Hepatol 2005;17:1111–1117.PubMedCrossRefGoogle Scholar
  147. 147.
    Thuluvath PJ, Maheshwari A, et al. A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig Dis Sci 2005;50:407–410.PubMedCrossRefGoogle Scholar
  148. 148.
    Schepke M, Kleber G, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004;40:65–72.PubMedCrossRefGoogle Scholar
  149. 149.
    D’Amico G, Pagliaro L, et al. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995;22:332–354.PubMedGoogle Scholar
  150. 150.
    de la Pena J, Rivero M, et al. Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial. Gastrointest Endosc 1999;49(4 pt 1):417–423.PubMedGoogle Scholar
  151. 151.
    Zargar SA, Javid G, et al. Endoscopic ligation versus sclerotherapy in adults with extrahepatic portal venous obstruction: a prospective randomized study. Gastrointest Endosc 2005;61:58–66.PubMedCrossRefGoogle Scholar
  152. 152.
    Patch D, Sabin CA, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology 2002;123:1013–1019.PubMedCrossRefGoogle Scholar
  153. 153.
    Bosch J, Garcia-Pagan JC. Prevention of variceal rebleeding. Lancet 2003;361:952–954.PubMedCrossRefGoogle Scholar
  154. 154.
    Karsan HA, Morton SC, et al. Combination endoscopic band ligation and sclerotherapy compared with endoscopic band ligation alone for the secondary prophylaxis of esophageal variceal hemorrhage: a meta-analysis. Dig Dis Sci 2005;50:399–406.PubMedCrossRefGoogle Scholar
  155. 155.
    Sarin SK, Wadhawan M, et al. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 2005;100:797–804.PubMedCrossRefGoogle Scholar
  156. 156.
    Villanueva C, Balanzo J, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996;334:1624–1629.PubMedCrossRefGoogle Scholar
  157. 157.
    Villanueva C, Minana J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001;345:647–655.PubMedCrossRefGoogle Scholar
  158. 158.
    de la Pena J, Brullet E, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. Hepatology 2005;41:572–578.PubMedCrossRefGoogle Scholar
  159. 159.
    Rossle M, Deibert P, et al. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet 1997;349:1043–1049.PubMedCrossRefGoogle Scholar
  160. 160.
    Pomier-Layrargues G, Villeneuve JP, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001;48:390–396.PubMedCrossRefGoogle Scholar
  161. 161.
    Tripathi D, Lui HF, et al. Randomised controlled trial of long term portography follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding. Gut 2004;53:431–437.PubMedCrossRefGoogle Scholar
  162. 162.
    Burroughs AK, Vangeli M. Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated metaanalysis. Scand J Gastroenterol 2002;37:249–252.PubMedCrossRefGoogle Scholar
  163. 163.
    Feu F, Ruiz del Arbol L, et al. Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology 1996;111:1291–1299.PubMedCrossRefGoogle Scholar
  164. 164.
    Jenkins SA, Shields R, et al. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage. Gut 1997;41:526–533.PubMedCrossRefGoogle Scholar
  165. 165.
    Encarnacion CE, Palmaz JC, et al. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol 1995;6:687–694.PubMedCrossRefGoogle Scholar
  166. 166.
    Abujudeh H, Parikh D, et al. Emergency transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding. Emerg Radiol 2005;11:183–185.PubMedCrossRefGoogle Scholar
  167. 167.
    Molmenti EP, Segev DL, et al. The utility of TIPS in the management of Budd-Chiari syndrome. Ann Surg 2005;241:978–981; discussion 982–983.PubMedCrossRefGoogle Scholar
  168. 168.
    Rossle M, Haag K, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165–171.PubMedCrossRefGoogle Scholar
  169. 169.
    Fillmore DJ, Miller FJ, et al. Transjugular intrahepatic portosystemic shunt: midterm clinical and angiographic follow-up. J Vasc Interv Radiol 1996;7:255–261.PubMedCrossRefGoogle Scholar
  170. 170.
    Wolff M, Hirner A. Current state of portosystemic shunt surgery. Langenbecks Arch Surg 2003;388:141–149.PubMedCrossRefGoogle Scholar
  171. 171.
    Rosemurgy AS, Serafini FM, et al. Transjugular intrahepatic portosystemic shunt versus small-diameter prosthetic H-graft portacaval shunt: extended follow-up of an expanded randomized prospective trial. J Gastrointest Surg 2000;4:589–597.PubMedCrossRefGoogle Scholar
  172. 172.
    Mariette D, Smadja C, et al. The Sugiura procedure: a prospective experience. Surgery 1994;115:282–289.PubMedGoogle Scholar
  173. 173.
    Haciyanli M, Gene H, et al. Results of modified Sugiura operation in variceal bleeding in cirrhotic and noncirrhotic patients. Hepatogastroenterology 2003;50:784–788.PubMedGoogle Scholar
  174. 174.
    Ma YG, Li XS, et al. Modified Sugiura procedure for the management of 160 cirrhotic patients with portal hypertension. Hepatobiliary Pancreat Dis Int 2004;3:399–401.PubMedGoogle Scholar
  175. 175.
    Brancatelli G, Federle MP, et al. Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients. Radiology 2001;219:61–68.PubMedGoogle Scholar
  176. 176.
    Caremani M, Lapini L, et al. Sonographic diagnosis of hydatidosis: the sign of the cyst wall. Eur J Ultrasound 2003;16:217–223.PubMedCrossRefGoogle Scholar
  177. 177.
    Descottes B, Glineur D, et al. Laparoscopic liver resection of benign liver tumors. Surg Endosc 2003;17:23–30.PubMedCrossRefGoogle Scholar
  178. 178.
    Fulcher AS, Sterling RK. Hepatic neoplasms: computed tomography and magnetic resonance features. J Clin Gastroenterol 2002;34:463–471.PubMedCrossRefGoogle Scholar
  179. 179.
    Haddad MC, Birjawi GA, et al. Unilocular hepatic echinococcal cysts: sonography and computed tomography findings. Clin Radiol 2001;56:746–750.PubMedCrossRefGoogle Scholar
  180. 180.
    Hori T, Nagata K, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol 2003;38:977–981.PubMedCrossRefGoogle Scholar
  181. 181.
    Hung CH, Changchien CS, et al. Sonographic features of hepatic adenomas with pathologic correlation. Abdom Imaging 2001;26:500–506.PubMedCrossRefGoogle Scholar
  182. 182.
    Hussain SM, Terkivatan T, et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004;24:3–17; discussion 18–19.PubMedCrossRefGoogle Scholar
  183. 183.
    Joosten J, Jager G, et al. Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. Eur J Surg Oncol 2005;31:1152–1159.PubMedCrossRefGoogle Scholar
  184. 184.
    Kehagias D, Moulopoulos L, et al. Focal nodular hyperplasia: imaging findings. Eur Radiol 2001;11:202–212.PubMedCrossRefGoogle Scholar
  185. 185.
    Koda M, Murawaki Y, et al. Combination therapy with trans-catheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study. Cancer 2001;92:1516–1524.PubMedCrossRefGoogle Scholar
  186. 186.
    Kodama Y, Fujita N, et al. Alveolar echinococcosis: MR findings in the liver. Radiology 2003;228:172–177.PubMedCrossRefGoogle Scholar
  187. 187.
    Lencioni RA, Allgaier HP, et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003;228:235–240.PubMedCrossRefGoogle Scholar
  188. 188.
    Leslie DF, Johnson CD, et al. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases. AJR Am J Roentgenol 1995;165:1403–1406.PubMedGoogle Scholar
  189. 189.
    Livraghi T, Solbiati L, et al. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the test-of-time approach. Cancer 2003;97:3027–3035.PubMedCrossRefGoogle Scholar
  190. 190.
    Machi J, Bueno RS, et al. Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma. World J Surg 2005;29:1364–1373.PubMedCrossRefGoogle Scholar
  191. 191.
    Mortele KJ, Praet M, et al. CT and MR imaging findings in focal nodular hyperplasia of the liver: radiologic-pathologic correlation. AJR Am J Roentgenol 2000;175:687–692.PubMedGoogle Scholar
  192. 192.
    Unal O, Sakarya ME, et al. Hepatic cavernous hemangiomas: patterns of contrast enhancement on MR fluoroscopy imaging. Clin Imaging 2002;26:39–42.PubMedCrossRefGoogle Scholar
  193. 193.
    Ding H, Kudo M, et al. Sonographic diagnosis of pancreatic islet cell tumor: value of intermittent harmonic imaging. J Clin Ultrasound 2001;29:411–416.PubMedCrossRefGoogle Scholar
  194. 194.
    Blumgart LH (ed.). Surgery of the Liver and Biliary Tract. New York: Churchill Livingstone; 1994.Google Scholar
  195. 195.
    Sabiston DE. Textbook of Surgery. 14th ed. Philadelphia: Saunders; 1991.Google Scholar
  196. 196.
    Henderson M, Barnes DS, Geisinger MA. Portal hypertension. Curr Probl Surg 1998;35:381–452.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Courtney Scaife
    • 1
  1. 1.Department of SurgeryUniversity of UtahSalt Lake CityUSA

Personalised recommendations